Compare Repligen Corporation Common Stock (RGEN) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs United Airlines Holdings Inc — how do they compare? Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B), while United Airlines Holdings Inc trades at $99.31 (market cap $32.12B). The key difference: United Airlines Holdings Inc is far larger — about 2.8× Repligen Corporation Common Stock's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and United Airlines Holdings Inc for 46 Days on average.
| RGEN | UAL | |
|---|---|---|
Market Cap | $11.31B | $32.12B |
Volume | 1,216,919 | 5,419,148 |
Sector | Health | Industrials |
52-Week High | $194.57 | $136.11 |
52-Week Low | $102.87 | $85.21 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $11.20B | $49.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
United Airlines (UAL) trades at $103.21, down 1.18% on the day, with a bearish technical signal from moving averages but oversold RSI suggesting potential near-term support. Fundamentally, the stock appears undervalued with a P/E of 9.67 and P/S of 0.54, supported by consistent earnings beats and a 5.56% net margin. Recent news highlights aggressive customer acquisition efforts targeting Delta's premium flyers with status-match offers and Starlink WiFi enhancements.
The outlook is mixed: strong analyst consensus (66% buy ratings) and a $158.10 price target imply 53% upside, but rising fuel costs and bearish technicals pose near-term headwinds. Earnings growth and market share gains from strategic moves present opportunity, while operational execution and cost management remain key risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
